2Bergmann KC, Lindemann L, Braun R, et al. Salmeterol/fluticasone propionate (50/250 txg) combination is superior to double dose fluticasone (500μg) for the treatment of symptomatic moderate asthma. Swiss Med Wkly ,2004,134:50 - 58.
3Loh LC, Lira BK, Raman S, et al. Budcsonide/formoterol combination therapy as both maintenance and reliever medication in moderate-to-severe asthma : a real-life effectiveness study of Malaysian patients. Med J Malaysia,2008,63 : 188 - 192.
5Kuna P,Peters MJ, Manjra AI, et al. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract,2007,61 (5) :725 - 36.
6Bousquet J, Boulet LP, Peters M J, et al. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med ,2007,101 (12) :2437 -2446.
2Global Initiative for Asthma. Global strategy for asthma management and prevention NHLBI/WHO workshop report. National Institutes of Health, National Heart, Lung and Blood Institutes,2006.
3Ito K,Lim S,Adcock IM,et al. Effect of low-dose therophynin on histone deacetylase activity in patients with mild asthma. Am J Respir Crit Care Med ,2000,161 : A614.
4Bousquet J, Boulet LP, Peters MJ. et al. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs high-dose salmeterol/fluticasone. Respir Med ,2007, Sep 28.
4Goldstein AB, Castile RG, Davis SD, et al. Bronchodilator responsiveness in normal infants and young children [ J 1. Am J Respir Crit Care Med, 2001, 164(3) : 447-454.
5Cazzola M, Matera MG. Novel long-acting bronchodilators for COPD and asthma [ J l. Br J Pharmacol, 2008, 155 (3): 291-299.
6Beeh KM, Derom E, Kanniess F, et al. Indaeaterol, a novel inhaled beta 2-agonist, provides sustained 24 h bronchodilation in asthma [J~. Eur Respir J, 2007, 29(5) : 871-878.
7Cates C J, Cates MJ. Regular treatment with salmeterol for chronic asthma: serious adverse events [ J ]. Cochrane Database Sys! Rev, 2008, 16(3): No: CD006363.
8Bateman ED, Bousquet J, Busse WW, et al. Stability of asthma control with regular treatment : an analysis of the Gaining Optimal Asthma ontrol (GOAL) study [ J]. Allergy, 2008, 63 (7) : 932- 938.
9Elkout H, McLay JS, Simpson CR, et al. A retrospective obser- vational study comparing rescue medication use in children on combined versus separate long-acting { beta t -agonists and cortico- steroids [J]. Arch Dis Child, 2010, 95(10) : 817-821.
10Moore PE. Exploration of the beta 2-adrenergic receptor regulatory regions: the next step in the holy grail of asthma pharmacogenet- ics research [ J]. Am J Physiol Lung Cell Mol Physiol, 2008, 294(2) : 190-195.
